ERD

HARMONY | Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026

01-01-2017

-

30-06-2023

Show more information

Organisation FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON

HARMONY PLUS | HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS

01-10-2020

-

31-03-2024

Show more information

Organisation FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON

RESSTORE | REgenerative Stem cell therapy for STroke in Europe

01-09-2015

-

31-08-2020

Show more information

Organisation FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON

RESILIENCE | Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines.

01-06-2021

-

31-05-2026

Show more information

Organisation FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON

IMPACT- AML | Master Framework and Pragmatic Clinical Trial for Relapse or Refractory Acute Myeloid Leukemia

01-04-2023

-

31-03-2028

Show more information

Organisation FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON

RESOLVE | Residual disease assessment in hematologic malignancies to improve patient-relevant outcomes across Europe (RESOLVE)

01-04-2024

-

31-03-2029

Show more information

Organisation FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON

oncNGS | NGS diagnostics in 21st century oncology: the best, for all, at all times

01-01-2020

-

30-04-2026

Show more information

Organisation FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON

MDS-RIGHT | Providing the right care to the right patient with MyeloDysplastic Syndrome at the right time

01-05-2015

-

31-10-2020

Show more information

Organisation FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON

COMBINE-CT | Combining CT diagnostic data and interventional approaches for futureproof cardiology care

01-11-2023

-

31-10-2027

Show more information

Organisation FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON

PANA | PROMOTING ACTIVE AGEING: FUNCTIONAL NANOSTRUCTURES FOR ALZHEIMER’S DISEASE AT ULTRA-EARLY STAGES.

01-03-2016

-

31-08-2021

Show more information

Organisation FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON

HERMES | Hybrid Enhanced Regenerative Medicine Systems

01-01-2019

-

31-12-2024

Show more information

Organisation FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON

RETHRIM | Restoring tissue regeneration in patients with visceral Graft versus Host Disease.

01-01-2015

-

31-12-2021

Show more information

Organisation FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON

Penphomet | PEN photoporation for the genetic engineering of therapeutic mesenchymal stromal cells and T cells

01-03-2024

-

28-02-2027

Show more information

Organisation FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON

Projects overview

Selected filters:

HARMONY | Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026

HARMONY PLUS | HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS

RESSTORE | REgenerative Stem cell therapy for STroke in Europe

RESILIENCE | Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines.

IMPACT- AML | Master Framework and Pragmatic Clinical Trial for Relapse or Refractory Acute Myeloid Leukemia

RESOLVE | Residual disease assessment in hematologic malignancies to improve patient-relevant outcomes across Europe (RESOLVE)

oncNGS | NGS diagnostics in 21st century oncology: the best, for all, at all times

MDS-RIGHT | Providing the right care to the right patient with MyeloDysplastic Syndrome at the right time

COMBINE-CT | Combining CT diagnostic data and interventional approaches for futureproof cardiology care

PANA | PROMOTING ACTIVE AGEING: FUNCTIONAL NANOSTRUCTURES FOR ALZHEIMER’S DISEASE AT ULTRA-EARLY STAGES.

HERMES | Hybrid Enhanced Regenerative Medicine Systems

RETHRIM | Restoring tissue regeneration in patients with visceral Graft versus Host Disease.

Penphomet | PEN photoporation for the genetic engineering of therapeutic mesenchymal stromal cells and T cells